China national experts share COVID-19 experiences with international community
Mission summary: WHO Field Visit to Wuhan, China 20-21 January 2020
WHO Statement regarding cluster of pneumonia cases in Wuhan, China
New survey shows overwhelming popular support for smoke-free indoor public places
Yi Yang Qian Xi participates in United Nations Youth Forum in NYC, in collaboration with WHO China, encourages young people to Yi qi lai ba!
WHO and China Sign New Agreement on Ebola Response
WHO applauds Xi’an going 100% smoke-free on 1 November, and calls for a Smoke-free Silk Road
Immunizations Save Lives
WHO China applauds move to make Xi’an 100% smoke-free, and encourages more cities to follow
WHO Statement on Rabies Vaccine Incident in China
WHO calls for stronger political commitment, more innovation and decentralized care to end TB
WHO and The Lancet spotlight social prescribing in new Western Pacific series
Strengthening health workforce capacity to tackle NCDs in the Pacific: WHO and the Korea Foundation for International Healthcare sign a donor agreement on UHC Day
Getting ready for the next pandemic: Western Pacific countries and areas carry out a key regional simulation exercise
Updated WHO data reveal persistence of violence against women and girls across the Western Pacific
25 Years Polio-Free: Western Pacific Countries Renew Commitment to Polio Eradication
WHO collaborating centres elevate partnerships to strengthen innovation and unity for health in the Western Pacific
Alcohol Leaves a Mark: WHO calls for collective action to expose alcohol harms and support stronger regulation
Western Pacific countries lead global efforts to make surgery safer and more accessible
WHO Western Pacific Member States take action on key health priorities
Countries urged to strengthen breastfeeding support and health systems to give every child a healthy start in life
Statement from the Joint Meeting of the Advisory Committee on Safety of Medicinal Products (ACSoMP) and the Global Advisory Committee on Vaccine Safety (GACVS) on the safe and appropriate use of GLP‑1 receptor agonists
WHO launches first global framework to help regulators advance greener pharmaceuticals
WHO updates treatment guidelines on visceral and post-kala-azar dermal leishmaniasis
